TY  - JOUR
AU  - Vigón, Lorena
AU  - Vázquez-Morón, Sonia
AU  - Berenguer, Juan
AU  - González-García, Juan
AU  - Jiménez-Sousa, Ma Ángeles
AU  - Guardiola, Josep M
AU  - Crespo, Manuel
AU  - de Los Santos, Ignacio
AU  - Von Wichmann, Miguel A
AU  - Carrero, Ana
AU  - Yélamos, María Belén
AU  - Gómez, Julián
AU  - Resino, Salvador
AU  - Martínez, Isidoro
AU  - GESIDA 3603b Cohort Study Group
PY  - 2019
DO  - 10.1038/s41598-019-48592-5
UR  - http://hdl.handle.net/10668/14425
T2  - Scientific reports
AB  - The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who...
LA  - en
KW  - Adult
KW  - Antibodies, Neutralizing
KW  - Antirheumatic Agents
KW  - Antiviral Agents
KW  - Cell Line, Tumor
KW  - Female
KW  - Genotype
KW  - HIV Infections
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Hepatitis C Antibodies
KW  - Humans
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Phylogeny
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Sustained Virologic Response
KW  - Viral Load
TI  - Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
TY  - research article
VL  - 9
ER  -